Oxymap is an Icelandic company that specializes in non-invasive ocular measurements. Their flagship product, the Oxymap T1, is an add-on for a fundus camera that allows for non-invasive retinal oxygen saturation and vessel-width measurements. With a strong focus on eye-care professionals and clinical researchers, Oxymap's novel imaging products and services contribute to the understanding of common eye diseases.

Founded in Reykjavik, Iceland, by a team of dedicated researchers, Oxymap has been at the forefront of ocular measurement technology since 2007-2008. The Oxymap T1, accompanied by user-friendly software, provides valuable metabolic and structural information through a single image. Renowned institutions worldwide rely on Oxymap T1 for their investigations.

Customer feedback is highly valued by Oxymap, driving continuous improvement of both the device and software. The company follows an ISO 13485-based quality management process, ensuring a seamless experience for their customers. Led by a distinguished leadership team, including CEO Arni Thor Arnason and esteemed ophthalmologist and founder Dr.

Einar Stefansson, Oxymap is committed to pushing the boundaries of ocular science and revolutionizing eye-care diagnostics